4th Quarter - Report

GEPHARDT GROUP GOVERNMENT AFFAIRS for COUNCIL FOR AMERICAN MEDICAL INNOVATION (CAMI)

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

medical innovation; access to medicines; FDA reform

LobbyistCovered position, as disclosed
CAITLIN DONOVAN —
RICHARD GEPHARDT —
ANDREA KING —

Contacted: Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

medical innovation; access to medicines; FDA reform

LobbyistCovered position, as disclosed
CAITLIN DONOVAN —
RICHARD GEPHARDT —
ANDREA KING —

Contacted: Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.